SET Bangkok, Market for Alternative Investment (mai) will list The Klinique Medical Clinic pcl, an aesthetics, plastic surgery, and wellness center, on November 7, under the ticker symbol “KLINIQ”. The company has a market capitalization at its initial public offering (IPO) of THB 5.39 billion (approx. USD 141.77 million).

mai President Prapan Charoenprawatt said that KLINIQ would list and start trading on mai in the services industry group.

KLINIQ provides services on aesthetic dermatology, plastic surgery, and advanced preventive and holistic health rehabilitation in compliance with medical principles, consisting of skin disease treatment, cosmetic skin treatment, weight loss, body contouring, surgery, wellness and regeneration by a team of medical specialists in aesthetic and cosmetic surgery certified by well-known institutions in Thailand, the United States and the United Kingdom with experience in providing medical examination & treatment services in skin diseases and surgery equipped with advanced technology under the brand “The Klinique”.

As of June 30, 2022, the company has 39 branches in leading department stores, covering 15 provinces, all over five regions of Thailand. The39 branches comprise 35 medical clinics, one surgical center at Siam Square in downtown Bangkok and three nail salons.

IPO set at price-to-earnings ratio (P/E ratio) of 31.78 times

KLINIQ has a paid-up capital of THB 110 million, consisting of 160 million existing ordinary shares and 60 million newly issued shares, with a par value of THB 0.50 each. It offered up to 6 million newly issued shares to the company’s directors, executives and employees, not over 9 million shares to the company’s patrons, and at least 45 million shares to institutional investors and individuals at the underwriters’ discretion, during October 28, 31, and November1, at THB 24.50 each, for a total of THB 1.47 billion.

The IPO price was equivalent to price-to-earnings ratio (P/E ratio) of 31.78 times. The earnings per share is equal to THB 0.77, which was calculated from the company’s net
profit of THB 169.60 million in the past four quarters (from July 1, 2021 to June 30, 2022), divided by fully diluted shares. Daol Securities (Thailand) pcl is the financial advisor and lead underwriter.

KLINIQ’s three major shareholders after the IPO are Thongwattana group (52.35
percent), Ekachai Medical Care pcl (7.27 percent), and Rattapol Kittichaitrakul
(7.16 percent). The company’s dividend policy is to pay no less than 40 percent
of net profit from the company’s separate financial statements after corporate
income tax, and legal and other reserves.

For more information on KLINIQ, please see the company’s prospectus at the
Securities and Exchange Commission’s website at; and for general
information, please visit as well as

mai News :mai welcomes aesthetic & wellness center “KLINIQ” on November 7

About the author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You May Also Like

Retail, banking and tourism sectors expected to gain from election outcome

The Thai stock market is likely to remain volatile in the short term as investors await more clarity on the formation of the new government and its policy implementation. However, in the long term, analysts expect that a stable and democratic government will be positive for the Thai economy and market sentiment.

SET jumps over 1500 as US inflation cools down

The market optimism extended beyond Asia, with European markets also seeing gains. Investors are closely monitoring the US inflation data, as it could influence central bank decisions and global market trends.

Why are Foreigners selling Thai stocks?

The main reasons for the foreign exodus are rising global interest rates, political uncertainty, weak corporate earnings, and a depreciating baht.